Oncology/Hematology

Ovarian Cancer

More in Ovarian Cancer

WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer

News, features, and commentary about cancer-related issues

Jun 29, 2023
Onco Break over a computer rendering of a cancer cell.
Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortages

News, features, and commentary about cancer-related issues

Jun 15, 2023
Onco Break over a computer rendering of a cancer cell.
Drug Shortage Worsens; AI, 3D Printing Potential Grows; Cancer's Effect on Function

News, features, and commentary about cancer-related issues

Jun 08, 2023
Onco Break over a computer rendering of a cancer cell.
New Ovarian Cancer Drug Extends Survival in Resistant Disease

"Practice changing" findings for tough-to-treat patient population

Jun 04, 2023
ASCO over a photo of McCormick place in Chicago, IL.
Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancer

Questions about anti-PD-L1 contribution, cost, and access to durvalumab, bevacizumab, olaparib

Jun 03, 2023
ASCO over a photo of McCormick place in Chicago, IL.
Many With Cancer Predisposition Diseases Unaware of Genetic Status

Moreover, a significant proportion do not qualify for genetic screening under current guidelines

Apr 19, 2023
AACR over a photo of Orange County Convention Center in Orlando, Florida.
Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Women

It's less clear-cut for postmenopausal women, study authors say

Apr 18, 2023
A computer rendering of a hysterectomy
Precancerous Lesions in Donor Organs; Dire Cancer Drug Shortage; CVD Ups Cancer Risk

News, features, and commentary about cancer-related issues

Apr 14, 2023
Onco Break over a computer rendering of a cancer cell.
VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy

Prospective study in heavily treated population is warranted, researcher says

Mar 30, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
Novel Strategies Show Winning Potential in Ovarian Cancer

High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib

Mar 28, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer

Responses in a fourth of patients, clinical benefit in up to 90%

Mar 26, 2023
SGO over a photo of the Tampa Convention Center in Tampa, Florida
Cancer and Heart Disease; Screening During COVID; CBD for Smoking Cessation

News, features, and commentary about cancer-related issues

Feb 17, 2023
Onco Break over a computer rendering of a cancer cell.
Faking a Cancer Dx? Fallopian Tube Removal; Trodelvy's New Breast Cancer Indication

News, features, and commentary about cancer-related issues

Feb 03, 2023
Onco Break over a computer rendering of a cancer cell.
Uterine Cancer Recognized as 9/11-Related; Working With Cancer; Post-Dx Suicide Risk

News, features, and commentary about cancer-related issues

Jan 20, 2023
Onco Break over a computer rendering of a cancer cell.
More in Ovarian Cancer

Continuing Medical Education

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Expert Strategies to Monitor and Mitigate Adverse Events During Breast Cancer Treatment

0.50 CME Credits
Clinical Case Challenge: Applying the Latest Evidence to Improve Outcomes in BRAF Mutant Advanced Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

0.50 CME Credits
Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma